SEC Filing Analysis: Nuo Therapeutics, Inc. (AURX)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director executed a "net exercise" of 50,000 stock options, resulting in a net acquisition of 40,909 shares by using other shares to cover the exercise cost.
• Market Impact: Minimal. This is a common, compensation-related event rather than a new investment decision based on market sentiment.

Company Information

Field	Value
Company	Nuo Therapeutics, Inc.
Ticker Symbol	AURX
CIK	0001091596
Industry	Surgical & Medical Instruments & Apparatus

Insider Information

Field	Value
Name	Mintz Paul
CIK	0001480208
Title/Position	n/a
Relationship	Director

Transaction Details

This filing reports a net exercise of stock options, which consists of two related transactions on the same day:

Field	Transaction 1 (Exercise)	Transaction 2 (Payment)
Form Type	4/A	4/A
Transaction Date	2025-12-09	2025-12-09
Transaction Code	M (Exercise of option)	F (Withholding shares for tax/exercise price)
Security Type	Common Stock	Common Stock
Shares Involved	50,000	9,091
Price Per Share	$0.40	$2.20
Total Value	$20,000	$20,000.20
Action	Acquired (A)	Disposed (D)
Ownership Type	Direct	Direct

Net Result: The insider acquired a net of 40,909 shares (50,000 - 9,091) and now holds 108,294 shares directly.

Financial Impact Assessment

Impact Evaluation

• Market Cap Context: Market capitalization data is not available, preventing a quantitative assessment of the transaction's materiality relative to the company's size.
• Ownership Concentration: The transaction increased the director's holdings from 67,385 to 108,294 shares. Without knowing the total shares outstanding, the percentage of ownership cannot be calculated.
• Transaction Significance: The transaction is classified as low significance. Option exercises, especially net exercises of expiring options, are typically part of an insider's compensation plan and do not reflect new, market-moving information or a change in sentiment. The total value is modest.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is not an open-market transaction. The exercise of options is a pre-planned event related to compensation and the impending expiration of the options (December 31, 2025). It does not signal new insider confidence in the company's future prospects.

Volume & Sentiment

• Expected Volume Impact: Negligible. The shares were not traded on the open market; the acquisition came from the exercise of options and the disposition was a withholding by the issuer.
• Sentiment Indicator: Neutral. This type of transaction is routine and does not typically influence market sentiment.

Additional Context

Transaction Notes

• Special Circumstances: As detailed in footnote 1, this was a "net exercise." The insider exercised an option to buy 50,000 shares at $0.40 each. To cover the $20,000 exercise price, the company withheld 9,091 shares, valued at the closing price of $2.20 on the transaction date. This allowed the insider to acquire the net shares without a cash payment.
• Timing: The options were set to expire on December 31, 2025, making this a timely exercise to realize their value before expiration.